Newsletter | November 28, 2023

11.28.23 -- Liquid Biopsy: The Next Evolution In Personalized Prostate Cancer Screening


Liquid Biopsy: The Next Evolution In Personalized Prostate Cancer Screening

The prostate-specific antigen (PSA) blood test has long been the gold standard in prostate cancer diagnostics. More recently, liquid biopsy, which includes the analysis of circulating tumor material in the blood or urine, has emerged as a promising non-invasive tool.

Why Lactococcus Lactis Might Be The Best Membrane Protein Factory

The bacteria lactococcus lactis has emerged as a promising alternative expression system for membrane proteins, which are difficult to manufacture. L. Lactis is inexpensive and easy to grow. It also doesn't produce endotoxins, which makes it a good fit for therapeutic applications.


AVROBIO On Patient Advocacy's Role in Clinical Trial Development & Recruitment

Fernanda Copeland, Global Head, Patient Advocacy & Engagement at AVROBIO, explains how to incorporate community education, patient feedback, and more to improve clinical trial development and recruitment.


Labcorp And Legacy Health Finalize Comprehensive Laboratory Relationship

Roche Launches Next-Gen qPCR System To Adv Clinical Needs In Molecular Diagnostics

Universal DX Announces Strategic Collaboration With Quest Diagnostics

Metabolon Partners With Trajan On Microsampling Solutions For Metabolomics Research

Roswell Park Launches Advanced, High-Speed Blood Cancer Test

Foundation Medicine Announces Collaboration With Pierre Fabre Laboratories

FDA Grants First Test For Chlamydia & Gonorrhea With At-Home Sample Collection

Edx Medical Announces Collaboration With Thermo Fisher Scientific

epitoMAP Inc., AACL & Nippon Zenyaku Kogyo Co., Ltd. Enter Into License Agreement

Legacy Opens Another State-Of-The-Art Andrology Lab In Hoboken, NJ

The Deerborne Group Projects Strong Growth For Liquid Biopsy Market


Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.